Sanofi files 2021 annual financial reports
Sanofi has filed its 2021 Form 20-F with the U.S. SEC and its Universal Registration Document with French regulators. The filings contain audited annual financial statements.
Paris – February 23, 2022 – Pharmaceutical company Sanofi announced today the filing of its 2021 annual financial reports with regulatory bodies in both the United States and France. The company submitted its Form 20-F to the U.S. Securities and Exchange Commission (SEC) and its "Document d’Enregistrement Universel" to the French Autorité des marchés financiers (AMF).
These filings contain the company's audited financial statements for the fiscal year 2021. Both documents are now accessible on Sanofi's corporate website, as well as through the official websites of the SEC and AMF. Investors can request hard copies of these reports free of charge.
Sanofi, which operates in approximately 100 countries, focuses on advancing healthcare through scientific research and development. The company aims to provide treatments and vaccines to millions of people globally.
The submission of these mandatory reports is a standard procedure for publicly traded companies to ensure transparency and provide stakeholders with comprehensive financial information. Sanofi is listed on EURONEXT Paris under the symbol SAN and on the NASDAQ under the symbol SNY.